Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × amivantamab × Clear all

Phase

Phase 2 7 Phase 1/2 2 Phase 1 1

Status

Sponsor Class

INDUSTRY 4 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 369 Radiotherapy 243 fludarabine 208 Gemcitabine 185 Cisplatin 181 Nivolumab 164 pembrolizumab 163 Paclitaxel 156 Magnetic Resonance Spectroscopy 143 Carboplatin 143 fludarabine phosphate 139 Bevacizumab 115 Irinotecan 113 Cytarabine 113 Temozolomide 112 Capecitabine 106 Specimen Handling 105 Radiosurgery 104 Radiation 101 Docetaxel 100 Dexamethasone 98 Etoposide 96 Biopsy 96 Ipilimumab 94 Fluorouracil 93 Rituximab 92 Oxaliplatin 91 Lenalidomide 88 Sorafenib 87 Filgrastim 87

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06632236 2025-04-25

5G-EMERALD

Institute of Cancer Research, United Kingdom

Phase 1 Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡